IRD
Ocuphire Pharma Announces Presentation on APX3330 at the ARVO 2024 Annual Meeting
Monday, May 6, 2024 1 min read
Key Takeaway: Ocuphire Pharma Announces Presentation on APX3330 at the ARVO 2024 Annual Meeting
Full Press Release Details
Ocuphire Pharma Announces Presentation on APX3330 at the ARVO 2024 Annual Meeting.